Balkrishna Industries Ltd (BLKI):

Balkrishna Industries Ltd has officially announced a consolidated sales of Rs. 1084.28 Cr for the quarter finished on 30-09-2019, which is -9.56% down from its previous quarter sales of Rs. 1198.93 Cr and .00% unchanged from its previous year’s same quarter sales. The firm has also announced its net profit after tax of Rs. 294.31 in the most recent quarter.
Outlook:
Balkrishna Industries Ltd is a buy call with a target of Rs. 885 and stop loss of Rs. 853; current market price: 845.65.
Aurobindo Pharma Ltd (ARBN):

Aurobindo Pharma Ltd has officially announced a consolidated sales of Rs. 5518.27 Cr for the quarter finished on 30-09-2019, which is 3.01% up from its previous quarter sales of Rs. 5356.84 Cr and 18.24% up from its previous year’s same quarter sales of Rs. 4667.12 Cr. The firm has also announced its net profit after tax of Rs. 639.46 in the most recent quarter.
Outlook:
Aurobindo Pharma Ltd is a buy call with a target of Rs. 430 and stop loss of Rs.398; current market price: 424.95.
Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/ shares mentioned.